Mohamed Samai

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 89 citations · Full text

Vaccination, Vaccine Safety, Two-dose Heterologous Ad26.zebov +9

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 85 citations · Full text

Vaccination, Vaccine Safety, Two-dose Heterologous Ad26.zebov +10

Lipotoxicity in renal proximal tubular cells: Relationship between endoplasmic reticulum stress and oxidative stress pathways

Elias N. Katsoulieris, Jon G. Mabley, Mohamed Samai et al. · Free Radical Biology and Medicine · 2010 · 77 citations

Oxidative Stress Pathways, Renal Function, Biochemistry +10

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak

Mohamed Samai, Jane F. Seward, Susan T. Goldstein et al. · The Journal of Infectious Diseases · 2018 · 74 citations · Full text

Vaccination, Vaccine Safety, Clinical Trial Design +14

Implementing an Ebola Vaccine Study — Sierra Leone

Marc‐Alain Widdowson, Stephanie J. Schrag, Rosalind J. Carter et al. · MMWR Supplements · 2016 · 67 citations · Full text

Disease Outbreak, Vaccine Hesitancy, Preventive Medicine +17